Our Theme
Achieving Equitable Progress:
A Call for Collaborative Action in a World of Growing Disparities
Welcome
Join us for the 19th Annual Scientific Conference hosted by the Academy for Sickle Cell and Thalassaemia (ASCAT), in collaboration with the prestigious British Society of Haematology and the European Hematology Association, supported by Eurobloodnet (EBN) and various patient groups. Discover the latest breakthroughs in haemoglobinopathies at this groundbreaking event. Whether you're a healthcare professional, researcher, or someone affected by these conditions, the ASCAT Conference offers a unique opportunity to stay informed.
Explore new advancements in diagnosis, treatment, and emerging therapies for Sickle Cell Disease and Thalassemia. Engage in insightful discussions, witness cutting-edge research presentations, and network with peers to contribute to the continuous evolution of this field.
Selected abstracts will be featured in HemaSphere (EHA) journals, ensuring widespread dissemination of vital discoveries. Additionally, earn CPD and CME credits to enhance your professional growth. Join us at ASCAT and be part of the progress in haemoglobinopathies.
Our Focus
In alignment with our conference's overarching goal, centered on "Improving the lives of those living with Sickle Cell Disease & Thalassaemia," our discussions emphasize the critical need for collective action to address these conditions. Despite advancements in therapies, including gene therapies, it is essential to acknowledge persistent systemic inequities in accessing these innovations, particularly within marginalized communities.
As we gather to explore innovative approaches, our priority is to foster collaboration among patient groups, medical professionals, researchers, policymakers, and affected communities to address these challenges. Through this congress, we aim to raise awareness, enhance care accessibility, and drive transformative research initiatives, all with the ultimate goal of ensuring equitable support and an improved quality of life for all individuals impacted by these haemoglobinopathies.
Our Objectives
Equitable Action:
Unite in addressing challenges faced by individuals with Sickle Cell Disease and Thalassaemia through collective commitment.
Innovation Focus:
Explore and share innovative approaches to revolutionize at the treatment and care of individuals with hemoglobinopathies.
Transformative Research:
Inspire and support research initiatives for groundbreaking developments in understanding and treating hemoglobinopathies.
Join us in making a meaningful impact on the lives of those affected by Sickle Cell Disease and Thalassaemia. Partner with us to support our objectives and contribute to the advancement of equitable care and ground-breaking research initiatives. Together, we can create lasting change and improve outcomes for individuals living with haemoglobinopathies.
Meet the esteemed members of the Scientific Programme Committee, who under the leadership of Professor Biree Andemariam, are shaping the intellectual landscape of ASCAT 2024.
Together this diverse and accomplished group ensures the program’s excellence, covering a spectrum of expertise to advance our understanding and treatment of Sickle Cell Disease and Thalassaemia.
Our Team
The Programme
This year’s program features five key elements:
| 1 | Sickle Cell Disease: Delve into the latest advancements in diagnosis, treatment, and care for individuals affected by Sickle Cell Disease. |
| 2 | Thalassaemia: Gain comprehensive insights into disease management strategies and emerging therapies for Thalassaemia patients. |
| 3 | Basic Research: Explore groundbreaking discoveries and experimental approaches driving innovation in the understanding and treatment of hemoglobinopathies. |
| 4 | Patient/Caregiver/Advocacy: Hear firsthand from patients, caregivers, and advocates, care and advocacy efforts within the community. |
| 5 | Meet the Expert: Engage in informal sessions with leading professionals, fostering knowledge exchange, collaboration, and the exploration of new ideas and approaches. |
Early bird discounts of 18% are available until May 31, 2024, for all registration categories. The early bird price will be extended to all participants who submit an abstract.
| Full Registration (4 days) |
Day Registration (1 day) |
|
|---|---|---|
| Corporate & Exhibitor | £420 | £180 |
| Medical Consultant | £420 | £180 |
| Medical Non-Consultant | £340 | £145 |
| Nurse & Service Manager | £250 | £110 |
| Student | £170 | £75 |
| Patient | £170 | £75 |
Join the Conversation
Connect with us on social media using #ASCAT2024 and stay updated on conference developments, speaker announcements, and more.
Sponsors and Partners
We extend our gratitude to our sponsors and partners for their invaluable support in making ASCAT CONFERENCE 2024 a reality.
Contact Us
For inquiries and additional information, please contact our conference team at ascatconference@outlook.com
